115
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Bioluminescence imaging of metabolites in a human tumour xenograft after treatment with hyperthermia and/or the radiosensitizer pimonidazole

&
Pages 235-245 | Received 21 Mar 1996, Accepted 21 Oct 1996, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mark W. Dewhirst, Chen-Ting Lee & Kathleen A. Ashcraft. (2016) The future of biology in driving the field of hyperthermia. International Journal of Hyperthermia 32:1, pages 4-13.
Read now

Articles from other publishers (3)

Nuria Vilaplana-Lopera, Maxym Besh & Eui Jung Moon. (2021) Targeting Hypoxia: Revival of Old Remedies. Biomolecules 11:11, pages 1604.
Crossref
Job Komen, Sanne M. van Neerven, Albert van den Berg, Louis Vermeulen & Andries D. van der Meer. (2021) Mimicking and surpassing the xenograft model with cancer-on-chip technology. eBioMedicine 66, pages 103303.
Crossref
Xionge Mei, Rosemarie ten Cate, Caspar M. van Leeuwen, Hans M. Rodermond, Lidewij de Leeuw, Dionysia Dimitrakopoulou, Lukas J. A. Stalpers, Johannes Crezee, H. Petra Kok, Nicolaas A. P. Franken & Arlene L. Oei. (2020) Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines. Cancers 12:3, pages 582.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.